Processa Pharma Stock (NASDAQ: PCSA) stock price, news, charts, stock research, profile.
Open | $1.71 |
Close | $1.67 |
Volume / Avg. | 9.48K / 1.35M |
Day Range | 1.67 - 1.74 |
52 Wk Range | 1.40 - 18.00 |
Market Cap | $4.63M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 1.89% |
Days to Cover | 1.48 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Processa Pharma (NASDAQ:PCSA) through any online brokerage.
Other companies in Processa Pharma’s space includes: Cingulate (NASDAQ:CING), Kiora Pharmaceuticals (NASDAQ:KPRX), Akanda (NASDAQ:AKAN), Jaguar Health (NASDAQ:JAGX) and Sonoma Pharmaceuticals (NASDAQ:SNOA).
There is no analysis for Processa Pharma.
Processa Pharma has a consensus price target of $4.75.
The stock price for Processa Pharma (NASDAQ: PCSA) is $1.62 last updated July 26, 2024 at 8:16 AM EDT.
There are no upcoming dividends for Processa Pharma.
Processa Pharma’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Processa Pharma.
Processa Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.